Cargando…

Anti-GAD65 autoantibody levels measured by ELISA and alternative types of immunoassays in relation to neuropsychiatric diseases versus diabetes mellitus type 1

BACKGROUND: Anti-GAD65 autoantibodies (GAD65-Abs) may occur in patients with epilepsy and other neurological disorders, but the clinical significance is not clear-cut. Whereas high levels of GAD65-Abs are considered pathogenic in neuropsychiatric disorders, low or moderate levels are only considered...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zong, Shenghua, Vinke, Anita M., Du, Peng, Hoffmann, Carolin, Mané-Damas, Marina, Molenaar, Peter C., Damoiseaux, Jan G. M. C., Losen, Mario, Rouhl, Rob P. W., Martinez-Martinez, Pilar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10248002/ https://www.ncbi.nlm.nih.gov/pubmed/37305746 http://dx.doi.org/10.3389/fneur.2023.1111063

Ejemplares similares

Autoantibodies in Neuropsychiatric Disorders
por: Hoffmann, Carolin, et al.
Publicado: (2016)

Neuronal Surface Autoantibodies in Neuropsychiatric Disorders: Are There Implications for Depression?
por: Zong, Shenghua, et al.
Publicado: (2017)

Unidentified Neuronal Surface IgG Autoantibodies in a Case of Hashimoto's Encephalopathy
por: Mané-Damas, Marina, et al.
Publicado: (2020)

Addendum: Hoffmann, C.; et al. Autoantibodies in Neuropsychiatric Disorders. Antibodies 2016, 5, 9
por: Hoffmann, Carolin, et al.
Publicado: (2018)

Novel neuronal surface autoantibodies in plasma of patients with depression and anxiety
por: Zong, Shenghua, et al.
Publicado: (2020)

Autoimmune Encephalitis With mGluR1 Antibodies Presenting With Epilepsy, but Without Cerebellar Signs: A Case Report
por: Vinke, Anita M., et al.
Publicado: (2022)

Decline in Titers of Anti-Idiotypic Antibodies Specific to Autoantibodies to GAD65 (GAD65Ab) Precedes Development of GAD65Ab and Type 1 Diabetes
por: Larsson, Helena Elding, et al.
Publicado: (2013)

An Analysis of the Cross-Reactivity of Autoantibodies to GAD65 and GAD67 in Diabetes
por: Jayakrishnan, Bindu, et al.
Publicado: (2011)

ELISA Test for Analyzing of Incidence of Type 1 Diabetes Autoantibodies (GAD and IA2) in Children and Adolescents
por: Delic-Sarac, Marina, et al.
Publicado: (2016)

GAD65 Autoantibodies Detected by Electrochemiluminescence Assay Identify High Risk for Type 1 Diabetes
por: Miao, Dongmei, et al.
Publicado: (2013)

Autoantibodies to neurotransmitter receptors and ion channels: from neuromuscular to neuropsychiatric disorders
por: Martinez-Martinez, Pilar, et al.
Publicado: (2013)

Anti-Idiotypic Antibody Specific to GAD65 Autoantibody Prevents Type 1 Diabetes in the NOD Mouse
por: Wang, Xin, et al.
Publicado: (2012)

Impact of GAD65 and IA2 autoantibodies on islet allograft survival
por: Lemos, Joana R. N., et al.
Publicado: (2023)

Differential HLA Association of GAD65 and IA2 Autoantibodies in North Indian Type 1 Diabetes Patients
por: Chuzho, Neihenuo, et al.
Publicado: (2021)

GAD65 autoantibodies and glucose tolerance in offspring born to women with and without type 1 diabetes (The EPICOM study)
por: Knorr, Sine, et al.
Publicado: (2021)

GAD65 Autoantibody Responses in Japanese Latent Autoimmune Diabetes in Adult Patients
por: Maruyama, Taro, et al.
Publicado: (2008)

Comparison of Radioimmunoprecipitation With Luciferase Immunoprecipitation for Autoantibodies to GAD65 and IA-2β
por: Burbelo, Peter D., et al.
Publicado: (2010)

Autoantibodies to N-terminally Truncated GAD(65)(96-585): HLA Associations and Predictive Value for Type 1 Diabetes
por: Pöllänen, Petra M, et al.
Publicado: (2021)

An analytical comparison of three immunoassay platforms for subpicomolar detection of protein biomarker GAD65
por: Costa, Olivier R., et al.
Publicado: (2018)

Bivalent GAD autoantibody ELISA improves clinical utility and risk prediction for adult autoimmune diabetes
por: Kawasaki, Eiji, et al.
Publicado: (2023)

Are T-Cell Responses to GAD65 Influential in Type 1 Diabetes?
por: Quinn, Anthony
Publicado: (2009)

Research of anti-GAD and anti-IA2 autoantibodies by ELISA test in a series of Moroccan pediatric patients with diabetes type 1
por: Belhiba, O, et al.
Publicado: (2020)

Catatonic Schizophrenia Associated With Cerebrospinal GAD65 Autoantibodies: Case Report and Literature Review
por: Hansen, Niels, et al.
Publicado: (2022)

Similarities between bacterial GAD and human GAD65: Implications in gut mediated autoimmune type 1 diabetes
por: Bedi, Suhana, et al.
Publicado: (2022)

CD226 rs763361 Is Associated with the Susceptibility to Type 1 Diabetes and Greater Frequency of GAD65 Autoantibody in a Brazilian Cohort
por: Mattana, Teresa Cristina Colvara, et al.
Publicado: (2014)

GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies
por: Liimatainen, Suvi, et al.
Publicado: (2018)

A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodies
por: Strippel, Christine, et al.
Publicado: (2022)

Elevated Serum GAD65 and GAD65-GADA Immune Complexes in Stiff Person Syndrome
por: Gu Urban, Gucci Jijuan, et al.
Publicado: (2015)

Recognition of Posttranslationally Modified GAD65 Epitopes in Subjects With Type 1 Diabetes
por: McGinty, John W., et al.
Publicado: (2014)

Optimized purification strategies for the elimination of non-specific products in the isolation of GAD65-specific monoclonal autoantibodies
por: Jiang, Wei, et al.
Publicado: (2016)

A Longitudinal Study of GAD65 and ICA512 Autoantibodies During the Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 (DPT-1) Participants
por: Sosenko, Jay M., et al.
Publicado: (2011)

Meningoencephalitis associated with GAD65 autoimmunity
por: Kuang, Zuying, et al.
Publicado: (2023)

GAD65 Antibody-Associated Epilepsy
por: Valinčiūtė, Justina, et al.
Publicado: (2023)

How Much GAD65 Do You Have? High Levels of GAD65 Antibodies in Autoimmune Encephalitis
por: Gaspard, Nicolas
Publicado: (2020)

Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome
Publicado: (1993)

Evidence That HLA Class I and II Associations With Type 1 Diabetes, Autoantibodies to GAD and Autoantibodies to IA-2, Are Distinct
por: Howson, Joanna M.M., et al.
Publicado: (2011)

Alpha7 acetylcholine receptor autoantibodies are rare in sera of patients diagnosed with schizophrenia or bipolar disorder
por: Hoffmann, Carolin, et al.
Publicado: (2018)

Peripheral blood mononuclear cells reactivity in recent-onset type I diabetes patients is directed against the leader peptide of preproinsulin, GAD65(271-285) and GAD65(431-450)
por: Jores, Rita D., et al.
Publicado: (2023)

No Contribution of GAD-65 and IA-2 Autoantibodies around Time of Diagnosis to the Increasing Incidence of Juvenile Type 1 Diabetes: A 9-Year Nationwide Danish Study
por: Thorsen, Steffen U., et al.
Publicado: (2016)

Detection of Antibodies Directed to the N-Terminal Region of GAD Is Dependent on Assay Format and Contributes to Differences in the Specificity of GAD Autoantibody Assays for Type 1 Diabetes
por: Williams, Alistair J.K., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qvbs1hcu8svoa9fdgin2ip0vr0